- Home
- GIFT vs JSPR Comparison
GIFT vs JSPR Comparison
Compare GIFT & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GIFT | JSPR |
|---|---|---|
| Founded | 1999 | 2018 |
| Country | United States | United States |
| Employees | N/A | 64 |
| Industry | Catalog/Specialty Distribution | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.1M | 34.7M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | GIFT | JSPR |
|---|---|---|
| Price | $0.93 | $1.15 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $18.13 |
| AVG Volume (30 Days) | 59.4K | ★ 257.4K |
| Earning Date | 03-18-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $7.20 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.73 | $1.11 |
| 52 Week High | $2.38 | $7.19 |
Technical Indicators
Market Signals| Indicator | GIFT | JSPR |
|---|---|---|
| Relative Strength Index (RSI) | 54.06 | 35.08 |
| Support Level | $0.73 | $1.11 |
| Resistance Level | $1.16 | $1.44 |
| Average True Range (ATR) | 0.10 | 0.07 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 67.61 | 6.67 |
Price Performance
Historical ComparisonAbout GIFT RDE Inc.
Giftify Inc through its wholly-owned subsidiary, has been in the business of connecting digital consumers, businesses and communities with dining and merchant deal options throughout the United States. The company connects digital consumers, businesses, and communities offering dining and merchant deal options nationwide restaurants, and retailers to customers. The Company buys merchant gift cards from the general public and distributors at a discount and then resells them at a markup.
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.